10 results on '"Nishimaki H"'
Search Results
2. Iliac neck dilatation causes rupture of abdominal aortic aneurysm previously treated with endovascular aortic aneurysm repair.
- Author
-
Fuchigami M, Ogawa Y, Chiba K, Komagamine M, Nawata S, Kinebuchi S, Mimura H, Miyairi T, and Nishimaki H
- Abstract
A 78-year-old male had undergone endovascular aortic aneurysm repair (EVAR) 7 years prior to presentation. Although the sac was stable 6 months ago, the patient presented with shock at arrival, and CT showed aortic rupture with rapid expansion due to type Ib endoleak caused by iliac neck dilatation (IND). The aneurysm sac was excluded using an endovascular strategy. Bell-bottom iliac limbs can cause IND associated with type Ib endoleak. Additionally, the risk of rupture is high when re-expansion of an aneurysm occurs after sac regression after EVAR. Therefore, close follow-up is mandatory for patients with IND after EVAR., (© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2023
- Full Text
- View/download PDF
3. Outcomes of embolization procedures for type II endoleaks following endovascular abdominal aortic repair.
- Author
-
Iwakoshi S, Ogawa Y, Dake MD, Ono Y, Higashihara H, Ikoma A, Nakai M, Taniguchi T, Ogi T, Kawada H, Tamura A, Ieko Y, Tanaka R, Sohgawa E, Nagatomi S, Woodhams R, Ikeda O, Mori K, Nishimaki H, Koizumi J, Senokuchi T, Hagihara M, Shimohira M, Takasugi S, Imaizumi A, Higashiura W, Sakaguchi S, Ichihashi S, Inoue T, Inoue T, and Kichikawa K
- Subjects
- Male, Humans, Female, Endoleak diagnostic imaging, Endoleak etiology, Endoleak therapy, Treatment Outcome, Time Factors, Risk Factors, Retrospective Studies, Blood Vessel Prosthesis Implantation adverse effects, Endovascular Procedures adverse effects, Aortic Aneurysm, Abdominal diagnostic imaging, Aortic Aneurysm, Abdominal surgery, Aortic Aneurysm, Abdominal complications, Embolization, Therapeutic adverse effects, Embolization, Therapeutic methods
- Abstract
Objective: The objective of this study was to investigate the mid-term outcomes of embolization procedures for type II endoleak after endovascular abdominal aortic repair, and clarify the risk factors for aneurysm enlargement after embolization procedures., Methods: This was a retrospective multicenter registry study enrolling patients who underwent embolization procedures for type II endoleaks after EVAR from January 2012 to December 2018 at 19 Japanese centers. The primary end point was the rate of freedom from aneurysm enlargement, more than 5 mm in the aortic maximum diameter, after an embolization procedure. Demographic, procedural, follow-up, and laboratory data were collected. Continuous variables were summarized descriptively, and Kaplan-Meier analyses and a Cox regression model were used for statistical analyses., Results: A total of 315 patients (248 men and 67 women) were enrolled. The average duration from the initial embolization procedure to the last follow-up was 31.6 ± 24.6 months. The rates of freedom from aneurysm enlargement at 3 and 5 years were 55.4 ± 3.8% and 37.0 ± 5.2%, respectively. A multivariate analysis revealed that a larger aortic diameter at the initial embolization procedure and the presence of a Moyamoya endoleak, defined as heterogeneous contrast opacity with an indistinct faint border, were associated with aneurysm enlargement after embolization management., Conclusions: The embolization procedures were generally ineffective in preventing further expansion of abdominal aortic aneurysms in patients with type II endoleaks after EVAR, especially in patients with a large abdominal aortic aneurysm and/or a presence of a Moyamoya endoleak., (Copyright © 2022 Society for Vascular Surgery. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Influence of Timing After Thoracic Endovascular Aortic Repair for Acute Type B Aortic Dissection.
- Author
-
Miyairi T, Miyata H, Chiba K, Nishimaki H, Ogawa Y, Motomura N, and Takamoto S
- Subjects
- Aged, Aged, 80 and over, Aortic Dissection mortality, Aortic Aneurysm, Thoracic mortality, Female, Humans, Japan, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Aortic Dissection surgery, Aortic Aneurysm, Thoracic surgery, Endovascular Procedures adverse effects, Postoperative Complications epidemiology, Time-to-Treatment
- Abstract
Background: This study aimed to analyze the influence of the timing of intervention from presentation of symptoms to thoracic endovascular aortic repair (TEVAR) and its relation to major complications. Data were collected from the Japan Adult Cardiovascular Surgery Database., Methods: We retrospectively analyzed the data of 680 patients who underwent TEVAR for acute and subacute type B dissection between January 2008 and January 2013., Results: Thoracic endovascular aortic repair for type B dissection was performed in 680 patients: 295 repairs were performed within 24 hours of presentation of symptoms (hyperacute); 97 between 24 hours and 14 days (acute); and 288 between 14 days and 6 weeks (subacute). Hyperacute patients more frequently had immediate life-threatening complications from type B dissection such as rupture or malperfusion than did acute or subacute patients (41.0% [121 of 295] versus 7.2% [7 of 97] versus 4.2% [12 of 288]; p < 0.001; and 17.3% [51 of 295] versus 8.3% [8 of 97] versus 5.6% [16 of 288]; p < 0.001, respectively). Operative mortality and severe complications including aortic dissection were more common among hyperacute patients (11.9% [35 of 295] versus 0% [0 of 97] versus 1.7% [5 of 288]; p < 0.001; and 32.5% [96 of 295] versus 10.3% [10 of 97] versus 8.3% [24 of 288]; p < 0.001, respectively) and did not differ significantly between acute and subacute patients (p = 0.191 and p = 0.553, respectively)., Conclusions: Although TEVAR performed for aortic dissection within 24 hours of presentation of symptoms was associated with worse outcomes, TEVAR performed between 24 hours and 14 days, as compared with TEVAR between 14 days and 6 weeks, does not appear to increase the risk of perioperative complications., (Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
5. Hybrid treatment combining emergency surgery and intraoperative interventional radiology for severe trauma.
- Author
-
Kataoka Y, Minehara H, Kashimi F, Hanajima T, Yamaya T, Nishimaki H, and Asari Y
- Subjects
- Blood Transfusion, Hemostasis, Humans, Japan epidemiology, Retrospective Studies, Trauma Centers, Treatment Outcome, Wounds and Injuries therapy, Angiography, Digital Subtraction, Craniotomy, Embolization, Therapeutic methods, Laparotomy, Radiography, Interventional methods, Thoracotomy, Wounds and Injuries diagnostic imaging
- Abstract
Object: To evaluate the efficacy of hybrid treatment combining emergency surgery and intraoperative interventional radiology (IVR) for severe trauma., Patients and Methods: The records of 63 severely injured patients who underwent concurrent emergency surgery and IVR at our emergency centre from 1999 through 2013 were retrospectively reviewed. Mobile digital subtraction angiography device was used in the operating room when performing IVR. Patients undergoing hybrid treatment combining intraoperative IVR and emergency surgery (intraoperative IVR group) were compared with those undergoing IVR in the angiography suite before or after emergency surgery (control group)., Results: Thirteen patients underwent hybrid treatment (intraoperative IVR group). Of these 13 patients, 7 underwent treatment for abdominal organ injuries, and 6 for multiregional injuries. Emergency operations were laparotomy (n=12), thoracotomy (n=1), craniotomy (n=1), and haemostasis of the lower extremities (n=1). Five patients underwent damage control surgery. IVR included transarterial embolisation (n=12), endovascular stent or stent-graft placement (n=2), and embolisation of a portal vein by laparotomy (n=2). The mean ISS was 40. The actual overall survival rate was 85%, and the probability of survival (Ps) was 62%. The control group included 45 patients. Five patients who met exclusion criteria were not included in the control group. Age, ISS, RTS, Ps, pH and base excess on arrival, and blood transfusion volume during operation and IVR did not differ significantly between the groups. Total time during operation and IVR was significantly shorter in the intraoperative IVR group than in the control group (229 [SD 72]min vs. 355 [SD 169]min; p=0.007). The mortality were 15 (95% CI 2-45) % in the intraoperative IVR group vs. 36 (95% CI 22-51) % in the control group., Conclusion: Hybrid treatment combining emergency surgery and intraoperative IVR can be a novel treatment strategy for severe trauma, and it will improve patient outcomes due to reduction of the time for resuscitation., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
6. Emergent endovascular stent-graft placement to treat ruptured Stanford type B acute aortic dissection.
- Author
-
Kawamura S, Nishimaki H, Lin ZB, Machii M, Isobe Y, Hayakawa K, and Soma K
- Subjects
- Aortic Dissection diagnostic imaging, Aortic Aneurysm, Thoracic diagnostic imaging, Aortic Rupture diagnostic imaging, Aortography, Humans, Male, Middle Aged, Minimally Invasive Surgical Procedures methods, Stents, Tomography, X-Ray Computed, Treatment Outcome, Aortic Dissection surgery, Aortic Aneurysm, Thoracic surgery, Aortic Rupture surgery, Blood Vessel Prosthesis Implantation methods
- Abstract
Uncomplicated Stanford type B acute aortic dissection, for which medical treatments are effective in most cases, is associated with a better prognosis than Stanford type A dissection. However, ruptured Stanford type B dissection still is associated with high mortality, because of the risks of open surgery and the complications of the disease. We report successful stent-graft placement in two patients with acute type B dissection with rupture, and discuss the advantages of stent-graft placement to treat ruptured acute type B dissection.
- Published
- 2004
- Full Text
- View/download PDF
7. A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line.
- Author
-
Nishimaki H, Kasai K, Kozaki Ki, Takeo T, Ikeda H, Saga S, Nitta M, and Itoh G
- Subjects
- Amides pharmacology, Apoptosis, Blotting, Western, Carcinoma, Squamous Cell metabolism, Cell Cycle, Cell Division, Cell Line, Tumor, Cell Separation, Culture Media, Conditioned pharmacology, Dose-Response Relationship, Drug, Enzyme Inhibitors pharmacology, Flow Cytometry, G1 Phase, Hedgehog Proteins, Humans, Intracellular Signaling Peptides and Proteins, Mouth Neoplasms metabolism, Protein Serine-Threonine Kinases metabolism, Pyridines pharmacology, S Phase, Signal Transduction, Time Factors, Veratrum Alkaloids pharmacology, rho-Associated Kinases, Trans-Activators metabolism
- Abstract
Sonic hedgehog (Shh) is a secreted morphogen crucial for appropriate cellular proliferation during mammalian development. The activated Shh signaling is known to predispose to human tumors such as medulloblastoma and basal cell carcinoma, while a role of Shh signaling in the other common tumors is still controversial. Here we showed the overexpression of Shh in five cell lines among 14 human oral squamous cell carcinoma (OSCC) cell lines. One of the Shh-expressing OSCC cell lines HSQ-89 showed the inhibition of G1/S transition and apoptotic cell death by treatment with Cyclopamine, a steroidal alkaloid that blocks the intracellular Shh signaling. Furthermore, we found that treatment with Y-27632, a specific inhibitor of Rho-associated kinase, mimicked the effect of Cyclopamine on the cell cycle progression of HSQ-89. Our study revealed the involvement of activated Shh signaling in the cellular proliferation of OSCC cells, indicating Shh signaling might be a good therapeutic target for OSCC.
- Published
- 2004
- Full Text
- View/download PDF
8. Gluteal muscle necrosis following transcatheter angiographic embolisation for retroperitoneal haemorrhage associated with pelvic fracture.
- Author
-
Takahira N, Shindo M, Tanaka K, Nishimaki H, Ohwada T, and Itoman M
- Subjects
- Adolescent, Adult, Aged, Buttocks, Female, Hemorrhage etiology, Humans, Injury Severity Score, Male, Middle Aged, Necrosis, Treatment Outcome, Embolization, Therapeutic adverse effects, Fractures, Bone pathology, Hemorrhage therapy, Muscle, Skeletal pathology, Pelvic Bones injuries, Retroperitoneal Space
- Abstract
Transcatheter angiographic emobilisation has been used as an effective control of haemorrhage associated with pelvic fracture. Although few complications of this procedure have been reported, gluteal muscle necrosis occurs occasionally. We assessed the type of pelvic fracture, concomitant injury, embolic site, embolic materials, and outcome in cases of gluteal muscle necrosis associated with angiographic embolisation for pelvic fracture-related haemorrhage, and investigated the factors associated with the development of gluteal muscle necrosis, one of the fatal complications of transcatheter angiographic embolisation. Five out of the 151 patients (incidence, 3.3%) who underwent transcatheter angiographic embolisation for haemorrhagic shock due to pelvic fracture developed gluteal muscle necrosis after embolisation. The five cases had injury severity scores ranging from 26 to 59 (mean 46.4). Three patients died (mortality, 60%) of subsequent sepsis and disseminated intravascular coagulation. These cases showed that transcatheter angiographic embolisation with gelatin sponge and/or steel coil, while effectively controlling bleeding, may also result in gluteal muscle necrosis. Aggressive management including intraarterial antibiotic treatment may have a role, but our numbers are too small to confirm this.
- Published
- 2001
- Full Text
- View/download PDF
9. Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells.
- Author
-
Nabata T, Fukuo K, Morimoto S, Kitano S, Momose N, Hirotani A, Nakahashi T, Nishibe A, Hata S, Niinobu T, Suhara T, Shimizu M, Ohkuma H, Sakurai S, Nishimaki H, and Ogihara T
- Subjects
- Animals, Calcium metabolism, Cells, Cultured, DNA Replication drug effects, Drug Interactions, Epoprostenol biosynthesis, Female, Glycosaminoglycans biosynthesis, Humans, Muscle, Smooth, Vascular metabolism, Rats, Rats, Wistar, Angiotensin II pharmacology, Interleukin-2 pharmacology, Muscle, Smooth, Vascular drug effects, Vasoconstrictor Agents pharmacology
- Abstract
Preincubation with interleukin-2 (IL-2), a T cell-derived cytokine, enhanced the increase in intracellular Ca2+ ([Ca2+]i) induced by angiotensin II (AII) in vascular smooth muscle cells (VSMC). IL-2 itself did not affect the basal [Ca2+]i level or the maximal response of [Ca2+]i increase induced by AII. Furthermore, IL-2-induced enhancement was not observed in the absence of extracellular Ca2+, suggesting that IL-2 enhances Ca2+ influx induced by AII. IL-2 also enhanced the stimulation of DNA synthesis induced by AII, although IL-2 alone did not stimulate DNA synthesis. Genistein, an inhibitor of protein tyrosine kinases, significantly inhibited IL-2-induced enhancement of both Ca2+ influx and DNA synthesis induced by AII. A neutralizing antibody against heparin-binding epidermal growth factor-like growth factor (HB-EGF) partially inhibited IL-2-induced enhancement of DNA synthesis induced by AII. These findings suggest that autocrine HB-EGF is partially involved in the mechanism of IL-2-induced enhancement of DNA synthesis. On the other hand IL-2 stimulated both glycosaminoglycan (GAG) and prostacyclin syntheses and enhanced the stimulation of both GAG and prostacyclin syntheses induced by AII. Therefore, IL-2 may play important roles in the pathogenesis of atherosclerosis and vascular disease by modulating the responsiveness to AII in VSMC.
- Published
- 1997
- Full Text
- View/download PDF
10. Ornithine decarboxylase induction during liver regeneration in IRS-1-deficient mice.
- Author
-
Furusaka A, Nishiyama M, Nishimaki H, Ogasawara Y, Tamemoto H, Yamauchi T, Tobe K, Kadowaki T, and Tanaka T
- Subjects
- Animals, CHO Cells, Cricetinae, Enzyme Induction, Hepatectomy, Humans, Insulin Receptor Substrate Proteins, Mice, Mice, Knockout, Mice, Mutant Strains, Phosphoproteins biosynthesis, Phosphoproteins metabolism, Receptor, Insulin biosynthesis, Receptor, Insulin metabolism, Recombinant Proteins biosynthesis, Recombinant Proteins metabolism, Transfection, Liver enzymology, Liver Regeneration, Ornithine Decarboxylase biosynthesis, Phosphoproteins deficiency
- Abstract
We investigated the induction of ornithine decarboxylase during liver regeneration after partial hepatectomy in IRS-1-deficient mice. There were no significant differences in ODC activity or the time course of changes in ODC activity between IRS-1-deficient mice and wild-type mice. PI 3'-kinase activity showed similar increases in both groups of mice. Furthermore, ODC induction in IRS-1 transfected CHO cells was studied after stimulation by addition of FCS. The maximal ODC activity was 2.5-fold greater in IRS-1-transfected CHO cells than in control CHO cells. Our results suggest that the IRS-1 pathway may be involved in ODC induction. The absence of a difference in ODC and PI 3'-kinase activity in the regenerating liver between IRS-1-deficient mice and wild-type mice may have been related to the compensatory effects of IRS-2/pp190 [Araki et al. Nature (1994) 372, 186-190; Tobe et al. J.Biol.Chem. (1995) 270, 5698-5701].
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.